Structure Therapeutics Inc ADR (NASDAQ:GPCR) price on Friday, June 13, fall -2.43% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $21.68.
A look at the stock’s price movement, the close in the last trading session was $22.22. Turning to its 52-week performance, $53.45 and $13.22 were the 52-week high and 52-week low respectively. Overall, GPCR moved -8.96% over the past month.
Structure Therapeutics Inc ADR’s market cap currently stands at around $1.25 billion, with investors looking forward to this quarter’s earnings report slated for in July.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend GPCR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GPCR’s current price about -4.86% and -2.91% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 44.01, while 7-day volatility ratio is 4.40% and 2.96% in the 30-day chart. Further, Structure Therapeutics Inc ADR (GPCR) has a beta value of -1.97, and an average true range (ATR) of 1.48. Analysts have given the company’s stock an average 52-week price target of $93, forecast between a low of $65 and high of $118. Looking at the price targets, the low is -199.82% off current price level while to achieve the yearly target high, price needs to move -444.28%. Nonetheless, investors will most likely welcome a -328.97% jump to $93 which is the analysts’ median price.
If we refocus on Structure Therapeutics Inc ADR (NASDAQ:GPCR), historical trading data shows that trading volumes averaged 948.70K over the past 3 months. The company’s latest data on shares outstanding shows there are 57.54 million shares.
The 4.94% of Structure Therapeutics Inc ADR’s shares are in the hands of company insiders while institutional holders own 93.69% of the company’s shares. Current price change has pushed the stock -20.06% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GPCR stock continues to rise going into the next quarter.
